COMP <GO>
LFVN vs TELO // DIVIDEND YIELD & FCF PAYOUT SAFETY
Lifevantage Corporation (Delaware) (NASDAQ) VS. Telomir Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: LFVN 6
— TELO 0
▲ DIVIDEND YIELD & FCF PAYOUT SAFETY LEADER: LFVN
LAST: $5.88 (+0.17%) • MKT CAP: $73.9M
dividend-safety
2.80%
LAST: $0.94 (-3.01%) • MKT CAP: $71.0M
dividend-safety
0.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LFVN VS. TELO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LFVN | TELO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 80.40% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 29.20% | -35.00% | +64.20 | LFVN | /roic <GO> |
| EV/EBITDA & P/E Valuation | 5.5x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 14.22% | -5.19% | +19.41 | LFVN | /fcf-yield <GO> |
| Operating Margin | 5.30% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 4.30% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 14.20% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 2.80% | 0.00% | +2.80 | LFVN | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.98 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 3/9 | +5.00 | LFVN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 49.6 | 29.3 | +20.30 | LFVN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 6.3x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $73.9M | $71.0M | $2.9M | LFVN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LFVN REV | TELO REV | LFVN GROSS % | TELO GROSS % | LFVN FCF | TELO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $228.5M | $0 | 80.4% | — | $10.5M | -$3.7M |
| FY 2024 | $200.2M | $0 | 79.3% | — | $10.0M | -$5.1M |
| FY 2023 | $213.4M | $0 | — | — | $6.8M | -$3.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LFVN // BETA —
TELO // BETA —